ArticleACS pharmacology & translational science2022

Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene.

Yuta Takamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.